Sense Neuro Diagnostics joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation

American Heart Association consortium advances development of evidence-based health tech solutions

Cincinnati, OH, July 1, 2024 – Sense Neuro Diagnostics, a startup developing non-invasive headsets to detect Traumatic Brain Injury (TBI) and stroke, has joined the American Heart Association Center for Health Technology & Innovation’s (the Center) Innovators’ Network. The Center is focused on building and fostering health technology relationships to develop innovative and scalable solutions.

The Innovators’ Network is a health care technology consortium that connects entrepreneurs, providers, researchers and payers. Innovators’ Network members also have access to the Association’s digital guidelines, recommendations, and best-in-class science as they develop digital healthcare technologies. Members collaborate with the Center in different ways, including the building of models for clinical outcome studies, lowering the significant cost of developing those studies independently, helping connect the science to technology, and providing evidence that a digital platform improves healthcare outcomes – a key concern for providers and payers.

“The Center aims to advance the rapid, efficient, and effective development of healthcare technology,” said Robert A. Harrington, M.D., FAHA, said Robert A. Harrington, M.D., FAHA, volunteer past president of the American Heart Association (2019-2020), chair of the American Heart Association’s Health Tech Advisory Group for the Center and the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine and provost for medical affairs of Cornell University. “Joining the Innovators’ Network gives members the opportunity to leverage the consortium and work toward broadening and deepening their engagement in this arena.”

“This is an incredible moment for us,” says Sense Neuro Diagnostics CEO Geoff Klass. “We’re building on momentum from our state-of-the art technology to bring much needed speed to detection, triage, and monitoring of brain injuries. We’re excited to connect with others who are passionate about bringing healthcare forward.”

About Sense Neuro Diagnostics

Sense Neuro Diagnostics joins the Innovators’ Network bringing with them non-invasive headsets which contain nine antennas that analyze the entire cranial vault.
Sense Neuro Diagnostics has developed technology that can detect and monitor a stroke or TBI that can be used in emergency rooms, ambulances, and the front line. Time is brain. On average in 2021, someone died of stroke every three minutes and 14 second in the United States. A single scan using a safe, low-power radio frequency scans the brain in just 2.5 seconds. Then the algorithm can break down the stroke by subtype: intracerebral hemorrhage (ICH), large vessel occlusion (LVO), or non-LVO.

Behind the Science: Non-Invasive Brain Scanners

Time is brain. You’ll hear us say that a lot at Sense Neuro Diagnostics. We’re on a mission to aid personnel to detect, monitor, and manage brain conditions in real-time. Once a brain cell dies, there’s no getting it back. If you or a loved one is riding in an ambulance going to a hospital ill-prepared for a brain injury or waiting in the ER for a CT scan, those could be crucial moments slipping away that you’ll never get back, possibly resulting in permanent disability or death.

Sense Neuro Welcomes Eric Bailey as Chief Commercial Officer

Cincinnati, OH - Sense Neuro Diagnostics today announced the hiring of Eric Bailey as Chief Commercial Officer. With experience as a seasoned CEO and expertise in technical and operational responsibilities in startup businesses, specifically in the market areas Sense Neuro intends to enter, we are proud to welcome Bailey to the team.

US FDA New Clinical for Sense Neuro Diagnostics

The new trial approved by the FDA Division of Neurosurgical, Neurointerventional, and Neurodiagnostic Devices will begin as soon as June 2023 and involve up to 300 patients at 30 sites in the United States, as well as Canada and India.

St. Elizabeth Healthcare Invests $250,000 In Sense Neuro Diagnostics

Medical technology startup Sense Neuro Diagnostics has received $250,000 in funding from St. Elizabeth Healthcare in Edgewood, Kentucky. The investment will help Sense Neuro Diagnostics as the company advances clinical trials in its effort to commercialize a non-invasive technology to monitor traumatic brain injuries.